Cargando…
Development and Validation of a Robust Ferroptosis-Related Gene Panel for Breast Cancer Disease-Specific Survival
Background: New biomarker combinations have been increasingly developed to improve the precision of current diagnostic and therapeutic modalities. Recently, researchers have found that tumor cells are more vulnerable to ferroptosis. Furthermore, ferroptosis-related genes (FRG) are promising therapeu...
Autores principales: | Li, Pei, Yang, Benlong, Xiu, Bingqiu, Chi, Yayun, Xue, Jingyan, Wu, Jiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655913/ https://www.ncbi.nlm.nih.gov/pubmed/34900981 http://dx.doi.org/10.3389/fcell.2021.709180 |
Ejemplares similares
-
The Prognoses of Young Women With Breast Cancer (≤35 years) With Different Surgical Options: A Propensity Score Matching Retrospective Cohort Study
por: Li, Pei, et al.
Publicado: (2022) -
Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma
por: Zhang, Anran, et al.
Publicado: (2021) -
A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients
por: He, Yikang, et al.
Publicado: (2021) -
Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma
por: Tian, Qi, et al.
Publicado: (2021) -
New Autophagy-Ferroptosis Gene Signature Predicts Survival in Glioma
por: Zhou, Liwei, et al.
Publicado: (2021)